No Data
VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald
VolitionRX Price Target Maintained With a $2.50/Share by Cantor Fitzgerald
Cantor Fitzgerald Reiterates Overweight on VolitionRX, Maintains $2.5 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates VolitionRX with a Overweight and maintains $2.5 price target.
VolitionRX (VNRX) Receives a Buy From Cantor Fitzgerald
Earnings Call Summary | VolitionRX(VNRX.US) Q1 2024 Earnings Conference
The following is a summary of the VolitionRx Limited (VNRX) Q1 2024 Earnings Call Transcript:Financial Performance:VolitionRx reported Q1 revenue of approximately $170,000, a 15% increase compared to
VolitionRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results.
VolitionRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results.
VolitionRX Is Maintained at Buy by EF Hutton
VolitionRX Is Maintained at Buy by EF Hutton